Microfluidic Assay Technology

An advanced molecular medicine platform providing fast and precise detection of genetic markers and disease indicators. The technology addresses unmet clinical needs in genetic disease screening and diagnosis.

A microfluidics-based platform for conducting blood tests with significantly reduced sample volume requirements. The technology integrates fluid handling, reagent storage, and analysis capabilities within a compact disposable cartridge format.

Microfluidic diagnostic chips designed for precise detection and diagnosis of tumors, infectious diseases, chronic conditions, and genetic disorders. These chips integrate microfluidic technology with multiple analytical platforms including fluorescent PCR, isothermal amplification, and immunoassay for applications in cancer screening, disease diagnosis, and therapeutic monitoring.

Microfluidic reader for rapid analysis and detection of biochemical markers in clinical and research settings. Enables precise measurement of diagnostic samples through microfluidic chip technology with integrated optical or electrochemical detection capabilities. Supports point-of-care testing and laboratory-based diagnostics for infectious disease, biomarker, and molecular analysis applications.

Automated molecular detection systems utilizing microfluidic technology for nucleic acid and protein analysis. These systems integrate sample preparation, amplification, and detection in a single microfluidic platform.

Diagnostic modules designed for immediate testing and analysis at the point of care, incorporating microfluidic technology and sensor integration.

A microfluidic-based fluorescence immunoassay kit designed for point-of-care testing (POCT) applications. The kit leverages microfluidic chip technology for biological detection and analysis. It is part of Novos Biotech's product line for molecular diagnostics and has been selected for innovative medical device demonstration projects.

Platform for manufacturing lateral flow assays for rapid detection of target substances in diagnostic applications. Provides cost-effective and user-friendly diagnostic solutions using precision dispensing technology. Enables high-throughput production of point-of-care test devices.

An innovative molecular detection platform utilizing microfluidic PCR technology capable of completing nucleic acid rapid detection within 30 minutes with high sensitivity and high specificity. The reagents are stable at room temperature without requiring cold chain storage, support customized multiplex detection, and can simultaneously detect up to 48 targets, providing an efficient solution for multi-pathogen detection.

Microfluidic platforms for immunological diagnostic assays. Enables rapid biomarker detection with reduced reagent consumption.

Integrated microfluidic platforms for molecular-level disease detection and pathogen identification. Combines sample preparation, amplification, and detection in a single miniaturized device for clinical diagnostics.

Microfluidic device for point-of-care testing and in vitro diagnostics applications. Enables precise fluid handling and sample analysis in compact formats, supporting rapid diagnostic workflows. FDA-registered and ISO-certified platform suitable for IVD manufacturing and clinical laboratory use.